Ductal Carcinoma In Situ with Microinvasion

Known as: DCISM, MIC, Microinvasive Breast Carcinoma 
Ductal carcinoma in situ of the breast with minimal stromal invasion. Lymph node involvement is uncommon and the prognosis is generally good.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
PURPOSE To compare the clinical-pathologic features and long-term outcomes for women with ductal carcinoma in situ (DCIS) vs… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Axillary lymph node dissection (ALND) in patients with ductal carcinoma in situ with microinvasion (DCISM) of the breast was… (More)
Is this relevant?
Review
2003
Review
2003
BACKGROUND Ductal carcinoma in situ (DCIS) accounts for nearly 20% of new breast cancer diagnoses and ductal carcinoma in situ… (More)
Is this relevant?
2002
Highly Cited
2001
Highly Cited
2001
The appropriateness of sentinel lymph node biopsy in the management of patients with biopsy diagnoses of ductal carcinoma in situ… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
W hat do Rational Rose, Simulink, and LabVIEW have in common? At first, these tools seem very different. Rational Rose (http… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Background: Axillary lymph node status is the strongest prognostic indicator of survival for women with breast cancer. The… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
BACKGROUND Widespread use of mammography has increased the detection of ductal carcinoma in situ with microinvasion (DCISM) in… (More)
Is this relevant?
1998
1998
BACKGROUND The natural history of patients with intraductal carcinoma (DCIS) and microinvasion is poorly defined, and the… (More)
Is this relevant?
1991
1991
Of 408 negative axillary node (NAN) patients surgically treated at Roswell Park Cancer Institute (Buffalo, NY, 1976 through 1987… (More)
Is this relevant?